FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127738863> ?p ?o ?g. }

• W2127738863 endingPage "217" @default.
• W2127738863 startingPage "207" @default.
• W2127738863 abstract "The proteasome inhibitor bortezomib, registered for Multiple Myeloma treatment, is currently explored for activity in solid tumors including non-small cell lung cancer (NSCLC). Here we studied the proteasome-based mechanisms underlying intrinsic and acquired bortezomib resistance in NSCLC cells. Various NSCLC cell lines displayed differential intrinsic sensitivities to bortezomib. High basal chymotrypsin- and caspase-like proteasome activities correlated with bortezomib resistance in these cells. Next, via stepwise selection, acquired bortezomib resistant cells were obtained with 8–70-fold increased resistance. Cross-resistance was found to proteasome inhibitors specifically targeting β-subunits, but not to the novel α-subunit-specific proteasome inhibitor (5AHQ). Consistently, bortezomib-resistant cells required higher bortezomib concentrations to induce G2/M arrest and apoptosis. Interestingly, bortezomib concentration-dependent caspase cleavage, Mcl-1 and NOXA accumulation remained intact in resistant H460 and SW1573 cells, while A549 resistant cells displayed different expression profiles suggesting additional and more protein specific adaptations. Furthermore, bortezomib-resistant cells exhibited increased levels of both constitutive and immuno-β-subunits. Sequence analysis of the bortezomib-binding pocket in the β5-subunit revealed Ala49Thr, Met45Val and Cys52Phe substitutions that were not previously described in solid tumors. Bortezomib-resistant cells displayed reduced catalytic proteasome activities and required higher bortezomib concentrations to achieve comparable inhibition of proteasome activity. Taken together, these findings establish that high basal levels of proteasome activity correlate with intrinsic bortezomib resistance. Furthermore, acquired bortezomib resistance in NSCLC is associated with proteasome subunit overexpression and emergence of mutant β5-subunits that likely compromise bortezomib binding. α-Subunit-specific proteasome inhibitors, however, can efficiently bypass this resistance modality." @default.
• W2127738863 created "2016-06-24" @default.
• W2127738863 creator A5005394469 @default.
• W2127738863 creator A5007946879 @default.
• W2127738863 creator A5013852274 @default.
• W2127738863 creator A5019308666 @default.
• W2127738863 creator A5025740932 @default.
• W2127738863 creator A5035296183 @default.
• W2127738863 creator A5042275454 @default.
• W2127738863 creator A5050502059 @default.
• W2127738863 creator A5070729528 @default.
• W2127738863 creator A5073965396 @default.
• W2127738863 date "2012-01-01" @default.
• W2127738863 modified "2023-09-27" @default.
• W2127738863 title "Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer" @default.
• W2127738863 cites W1490867178 @default.
• W2127738863 cites W1540671296 @default.
• W2127738863 cites W1960514362 @default.
• W2127738863 cites W1964602059 @default.
• W2127738863 cites W1966704794 @default.
• W2127738863 cites W1974010669 @default.
• W2127738863 cites W1978032094 @default.
• W2127738863 cites W1980223279 @default.
• W2127738863 cites W1984998337 @default.
• W2127738863 cites W1985275612 @default.
• W2127738863 cites W1985422401 @default.
• W2127738863 cites W1986036865 @default.
• W2127738863 cites W1987011447 @default.
• W2127738863 cites W1988545739 @default.
• W2127738863 cites W2000044224 @default.
• W2127738863 cites W2001742494 @default.
• W2127738863 cites W2006269123 @default.
• W2127738863 cites W2007688470 @default.
• W2127738863 cites W2008744347 @default.
• W2127738863 cites W2010163650 @default.
• W2127738863 cites W2011057102 @default.
• W2127738863 cites W2011457559 @default.
• W2127738863 cites W2016742872 @default.
• W2127738863 cites W2017937681 @default.
• W2127738863 cites W2023338496 @default.
• W2127738863 cites W2026043555 @default.
• W2127738863 cites W2029501972 @default.
• W2127738863 cites W2031403784 @default.
• W2127738863 cites W2033944464 @default.
• W2127738863 cites W2036211695 @default.
• W2127738863 cites W2039180923 @default.
• W2127738863 cites W2040363409 @default.
• W2127738863 cites W2053728180 @default.
• W2127738863 cites W2054298919 @default.
• W2127738863 cites W2054814252 @default.
• W2127738863 cites W2077247713 @default.
• W2127738863 cites W2086450157 @default.
• W2127738863 cites W2086634576 @default.
• W2127738863 cites W2110907871 @default.
• W2127738863 cites W2122597368 @default.
• W2127738863 cites W2123781000 @default.
• W2127738863 cites W2125194042 @default.
• W2127738863 cites W2126267349 @default.
• W2127738863 cites W2127064997 @default.
• W2127738863 cites W2127358965 @default.
• W2127738863 cites W2136951601 @default.
• W2127738863 cites W2163495162 @default.
• W2127738863 cites W2166761147 @default.
• W2127738863 cites W234617279 @default.
• W2127738863 cites W2398639705 @default.
• W2127738863 cites W4235721540 @default.
• W2127738863 doi "https://doi.org/10.1016/j.bcp.2011.10.009" @default.
• W2127738863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22027222" @default.
• W2127738863 hasPublicationYear "2012" @default.
• W2127738863 type Work @default.
• W2127738863 sameAs 2127738863 @default.
• W2127738863 citedByCount "67" @default.
• W2127738863 countsByYear W21277388632012 @default.
• W2127738863 countsByYear W21277388632013 @default.
• W2127738863 countsByYear W21277388632014 @default.
• W2127738863 countsByYear W21277388632015 @default.
• W2127738863 countsByYear W21277388632016 @default.
• W2127738863 countsByYear W21277388632017 @default.
• W2127738863 countsByYear W21277388632018 @default.
• W2127738863 countsByYear W21277388632019 @default.
• W2127738863 countsByYear W21277388632020 @default.
• W2127738863 countsByYear W21277388632021 @default.
• W2127738863 countsByYear W21277388632022 @default.
• W2127738863 countsByYear W21277388632023 @default.
• W2127738863 crossrefType "journal-article" @default.
• W2127738863 hasAuthorship W2127738863A5005394469 @default.
• W2127738863 hasAuthorship W2127738863A5007946879 @default.
• W2127738863 hasAuthorship W2127738863A5013852274 @default.
• W2127738863 hasAuthorship W2127738863A5019308666 @default.
• W2127738863 hasAuthorship W2127738863A5025740932 @default.
• W2127738863 hasAuthorship W2127738863A5035296183 @default.
• W2127738863 hasAuthorship W2127738863A5042275454 @default.
• W2127738863 hasAuthorship W2127738863A5050502059 @default.
• W2127738863 hasAuthorship W2127738863A5070729528 @default.
• W2127738863 hasAuthorship W2127738863A5073965396 @default.
• W2127738863 hasConcept C185592680 @default.
• W2127738863 hasConcept C203014093 @default.
• W2127738863 hasConcept C27740335 @default.

• next